OPKO Health, Inc. (0KCS.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 961.45M |
| Enterprise Value | 1.03B |
| P/E Ratio | -16.79 |
| PEG Ratio | -0.62 |
| Price/Sales Ratio | 2.03 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 2.19 |
| Enterprise/EBITDA | 25.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.12 |
| Operating Margin | -0.25 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.06 |
Income Statement
| Revenue | 606.88M |
| Revenue/Share | 0.78 |
| Gross Profit | 128.05M |
| EBITDA | -127.36M |
| Net Income | -225.68M |
| Diluted EPS | -0.3 |
Balance Sheet
| Total Cash | 300.76M |
| Total Cash/Share | 0.4 |
| Total Debt | 398.08M |
| Total Debt/Equity | 0.33 |
| Current Ratio | 3.35 |
| Book Value Per Share | 1.57 |
Price History
| 52-Week Change | 10.07 |
| 52-Week High | 2.23 |
| 52-Week Low | 0.85 |
| Moving Average 50 Days | 1.01 |
| Moving Average 200 Days | 1.47 |
Statistics
| Average Volume | 114,049 |
| Shares Outstanding | 746.33M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
